Abstract: This invention relates to a preventive and/or therapeutic agent for sarcopenia, comprising a prostaglandin D2 production inhibitor as an active ingredient.
Type:
Grant
Filed:
April 18, 2019
Date of Patent:
January 30, 2024
Assignees:
National University Corporation Tokyo University of Agriculture and Technolgy, Taiho Pharmaceutical Co., Ltd.